Conférenciers / Panélistes
-
Keynote Address - Quality Time: The consequences of quality improvement in radiotherapy
le 28 janvier 2026 de 17h30 EST À 18h30 EST
Timothy Hanna
Dr. Timothy Hanna is Professor of Oncology at Queen’s University and holds the CTAQ Endowed Chair in Health Policy and Health Economics. He serves as the Radiation Oncology Clinical Quality Lead for Ontario Health (Cancer Care Ontario), where he guides provincial initiatives to improve the quality, safety, and equity of radiotherapy services. Internationally recognized for his work on the impact of treatment timeliness, cancer system performance, and global radiotherapy access, he has contributed to landmark studies quantifying the survival effects of treatment delays and the worldwide shortage of radiotherapy capacity. His research program integrates health services, health economics, and cancer policy, with over 100 publications influencing practice and policy in Canada and abroad. Dr. Hanna is committed to bridging the care gap by aligning innovation, evidence, and systems design to deliver high-quality, equitable cancer care.
Núria Jornet PhD
The implementation of research into clinical practice has been one of my main priorities, as well as the improvement of treatment quality in radiation oncology.
This research work has resulted in 57 publications in peer-reviewed scientific journals (h-index = 21), approximately 250 conference communications, and 13 funded research projects.
Principal investigator of the CatClinART project on creating a permanent infrastructure on clinical audits in Radiotherapy in Catalonia, funded by the EU4Health programme (October 2024 – October 2027).
Researcher in the Kayak+ project (Pianoforte) (May 2025 – May 2029).
Course Director of the Quality Management Course of the European Society for Radiotherapy and Oncology (ESTRO).
Member of the Patient Safety Commission of the Spanish Society of Medical Physics (SEFM).
Expert in QUATRO audits (IAEA) and expert in EC projects EU-REST, QUADRANT, and the ESTRO Working Group on Quality Indicators.
Dr. Michael Milosevic
Dr. Milosevic is a radiation oncologist and clinician scientist at the Princess Margaret Cancer Centre, Toronto, and Professor of Radiation Oncology at the University of Toronto with over 250 peer reviewed publications. He is a former president of the Canadian Association of Radiation Oncology (CARO) and the founding chair of the Canadian Partnership for Quality in Radiotherapy (CPQR).
Caitlin Gillan RTT MEd PhD FCAMRT
A longtime clinician and educator, Dr Gillan is the Provincial Professional Practice Leader for Radiation Therapy for BC Cancer. With close to 20 years of experience as a radiation therapist, she leverages her clinical, research, leadership, and education background to advance innovative practice initiatives to the benefit of those with cancer and the providers that support their care.
Dr Gillan has an established academic and practical interest in quality and safety in radiotherapy care, and in interprofessional collaboration in the introduction of novel technologies. In 2022, she completed her doctoral studies through University of Toronto’s Institute of Health Policy, Management, and Evaluation, focusing on how healthcare professions are considering the impact of artificial intelligence on their practice. Pursuant to this work, she is a founding member of the Canadian Artificial Intelligence and Big Radiotherapy Data Alliance (CADRA), co-chairs the AI Professional Practice Advisory Council for the CAMRT, and is the Instructional Lead for the Digital Health and Data Analytics Program at the Michener Institute of Education at UHN.
Dr Gillan is a Clinical Associate Professor with the Division of Radiation Oncology in the University of British Columbia’s Department of Surgery, and an Associate Professor in the Department of Radiation Oncology at the University of Toronto.
Brian Liszewski M.R.T.(T.), BSc.
Brian Liszewski is a radiation therapist and Advisor for Radiation Therapy and Infrastructure Planning at Ontario Health (Cancer Care Ontario) whose career has been defined by a passion for quality, safety, and data-driven innovation in radiation oncology. Over nearly twenty years, he has advanced provincial and pan-Canadian initiatives through the Canadian Partnership for Quality Radiotherapy (CPQR), contributing to the development of the National System for Incident Reporting in Radiation Treatment (NSIR-RT) as well as pan-Canadian and international quality assurance guidelines and patient engagement frameworks.
As Co-founder of the Canadian Artificial Intelligence and Big Data in Radiotherapy Alliance (CADRA), Brian is helping to shape Canada’s AI-enabled future in oncology through projects focused on data harmonization, nomenclature standards, and responsible AI integration. He continues to bridge clinical insight with system-level strategy to drive safer, smarter, and more connected care across the country.
Grounded in quality and guided by innovation, Brian’s ongoing work connects clinical practice with data science to drive continuous improvement in radiation therapy safety, performance, and person-centered care.
Donna Murrell, PhD
Dr. Donna Murrell is a Medical Physicist and Clinician-Scientist at London Health Sciences Centre in London, Canada. She earned MSc and PhD degrees from the University of Western Ontario and is now an Assistant Professor in the Departments of Oncology and Medical Biophysics there. She leads the reirradiation group in London and is involved in international and national efforts to advance the field of reirradiation.
David Tiberi MD
Dr. Tiberi is a Radiation Oncologist and Assistant Professor in the Division of Radiation Oncology at The Ottawa Hospital. He specializes in radiotherapy for Genitouinary and Thoracic Malignancies as well as ablative radiotherapy for ventricular arrythmias .
His research interests include: reirradiation and ablative cardiac radiotherapy
Marija Popovic, PhD, FCCPM
Dr. Marija Popovic is a Medical Physicist at The Ottawa Hospital and an Affiliate Member of the Gerald Bronfman Department of Oncology at McGill University. Her clinical and research interests focus on dose accumulation, deformable image registration, and standardization of cumulative dose evaluation methods in reirradiation. Marija currently chairs the COMP Reirradiation Advancement Initiative. Internationally, she is an active contributor to several international working groups of the ESTRO Physics Reirradiation Working Group, ESTRO Reirradiation Focus Group, and the Reirradiaton Collaborative Group (ReCOG).
Greg Fox MRT(T)
Greg Fox graduated from Dawson College and began working at The Ottawa Hospital Cancer Center in 2001. He has over 20 years of experience in Treatment Planning across all disease sites, specializing in CNS, Lung and Genitourinary cancers. SBRT planning has been his main focus the last 5 years with the increased use of SBRT for spine, bone and nodal metastasis. He is the lead planner for ablative radiotherapy for ventricular arrythmias and also plans many of the complex lung re irradiation cases. Re-irradiation is an area of interest for him, and he is a member of the Thoracic Re-Irradiation Working Group for Ontario Health.
Dr Amanda Caissie
Dr. Amanda Caissie MD, PhD, FRCPC is Head of Dalhousie University’s Department of Radiation Oncology (DRO). Her contributions to national and international radiotherapy quality improvement initiatives include co-founder/co-lead of the Canadian Artificial intelligence and big Data in Radiotherapy Alliance (CADRA) and member of the Canadian Partnership for Quality Radiotherapy (CPQR) Steering committee as well as the American Association of Physicists in Medicine (AAPM) Big Data subcommittee. Aiming to align clinical and research priorities for digital health solutions across the continuum of cancer care, her academic interest lies in use of Big Data to support health learning systems.
Harry Ingleby, PhD, MCCPM
I'm an imaging physicist at CancerCare Manitoba, part of a provincial Imaging Physics group. I provide support for diagnostic x-ray modalities, including CT, radiography, fluoroscopy, and mammography and have CCPM certifications in mammography and diagnostic radiological physics. I also have faculty appointments at the University of Manitoba and teach in the medical physics graduate program and radiology residency program.
Andrea McNiven, PhD, FCCPM
Dr. Andrea McNiven is the Director of the Medical Physics Department at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary and is the Division Chief for Medical Physics in the Department of Oncology, University of Calgary. Involved in quality and safety initiatives in radiotherapy from education to clinical practice. One focus is treatment plan and delivery quality (e.g. author for CPQR technical quality control guideline on patient specific QC, active member of TG-360, physics lead for multiple HN CCTG trials and a physics CCTG representative on NCTN Physics Committee) and education (both education quality and education related to quality).
Carol-Anne Davis, AC(T), MSc, FCAMRT
Carol-Anne Davis is a radiation therapist with over 35 years of experience spanning clinical, educational and management roles. Currently she is the Provincial Director of Clinical Oncology for the Nova Scotia Health Cancer Care Program. Nationally Carol-Anne has volunteered with several key organizations: Accreditation Canada, (Radiotherapy/Cancer Care Working Group Member), the Canadian Association of Radiation Oncology (CARO) Quality and Standards Committee and the Canadian Partnership for Quality Radiotherapy (CPQR) steering committee. In recognition of her many volunteer roles and research activities, Carol-Anne became a Fellow of the CAMRT in 2015. Carol-Anne’s clinical interests reside in Quality and Safety, RT for H&N cancer population, imaging, scopes of practice and stereotactic body radiotherapy. Research interests include positron-emission-tomography, peer–review and RT outcomes. Currently Carol-Anne is the NS co-lead for the CPAC funded project: Pan-Canadian Cancer Data Strategy Implementation - Stream 2: A Unified Approach to Standardizing Nomenclature in Radiation Oncology.
Kristi MacKenzie; MHA, CHE
Kristi MacKenzie is the Executive Director of the Canadian Association of Provincial Cancer Agencies (CAPCA), where she works alongside national health leaders to collaboratively address key issues impacting cancer care delivery across Canada. She brings extensive experience from leadership roles at the provincial, regional, and local levels of the healthcare system. Prior to joining CAPCA, Kristi served as the Regional Cancer Program Director for the Hamilton Niagara Haldimand Brant Regional Cancer Program and as Director of Hematology at the Juravinski Hospital and Cancer Centre. She holds an Honours Bachelor of Science from the University of Toronto and a Master of Health Administration from the University of British Columbia. Kristi is also a Certified Health Executive with the Canadian College of Health Leaders. Throughout her career, Kristi has been recognized for her collaborative approach, strategic leadership, and ability to implement health system initiatives that enhance the quality and performance of care. She is a committed health promotion advocate with a strong passion for improving community health and advancing equitable access to care.
Lesley Buckley
Lesley Buckley is the associate head of medical physics at The Ottawa Hospital and holds clinical certifications in radiation oncology, diagnostic imaging and mammography physics. She is the radiation safety officer for the radiation medicine program and is deputy program director for the medical physics residency program. She is an Assistant Professor in the Department of Radiology, Radiation Oncology and Medical Physics at The University of Ottawa and is actively involved in teaching within both the radiation oncology and radiology programs. Her current clinical and research focus is primarily in quality improvement initiatives, imaging dose as applied to radiation therapy and in the development of regional approaches to quality assurance programs.
Marc Venturi
Marc is the Director for Accreditation at the Canadian Association of Radiologists (CAR) and leads the Health Artificial Intelligence Validation Network (HAIVN). He advances quality in medical imaging through CAR’s national accreditation programs and helps shape the responsible, real-world use of AI via CAR’s Artificial Intelligence Standing Committee and the HAIVN initiative—the focus of today’s talk. Previously, Marc streamlined clinical research operations at The Ottawa Hospital and the Ottawa Hospital Research Institute and contributed to setting national standards for clinical research. He holds a Bachelor of Science in Biotechnology and a Master’s in Health Administration.
Kathleen Surry PhD MCCPM
Dr. Kathleen Surry is Academic Medical Physicist at the Verspeeten Family Cancer Centre, London Health Sciences Centre, with clinical and research interests in HDR brachytherapy, and GYN cancer care, as well as process and documentation. She is an Assistant Professor in Oncology and the Director of the CAMPEP graduate program in Medical Biophysics at Western University, with a passion for teaching and mentorship and the importance of professionalism in clinical physics. Finally, Kathleen is the current COMP President, where she is honoured to be serving the Canadian Medical Physics community.
Charles Mayo PhD
Dr. Charles (Chuck) Mayo, PhD, is a distinguished medical physicist at the University of Michigan, who is internationally known for his groundbreaking work in several areas. He pioneered development of one of the first automated learning health system infrastructures for all treated patients and development of automated statistical and AI modeling tools. He has led in multiple international efforts in developing standardizations and APIs to reduce barriers to centralized and federated learning approaches. These include the AAPM TG-263 nomenclature, the Operational Ontology for Oncology (O3) and the CodeX HL7 FHIR radiation therapy data. Dr. Mayo has made significant contributions to the development of advanced treatment planning techniques that optimize patient outcomes. He has contributed in QUANTEC and PENTEC efforts in modeling. Developing software applications to improve driving clinical decision frameworks and impoving efficiency and safety is a consistent theme in his work in including release of open source applications. Dr. Mayo’s work in reirradiation and in organizing the Reirradiation Collaborative Group (ReCOG) has been instrumental in advancing therapeutic options for patients with recurrent cancers, offering new hope for challenging cases. He is an enthusiastic promoter of interdisciplinary, approaches to combining cutting-edge technology with patient-centered care.
Dr. David DeVries, PhD, MSc
David DeVries is a medical physicist at the Verspeeten Family Cancer Centre in London, Ontario, which he joined after completing his residency at the Verspeeten in August. David previously completed his PhD in medical biophysics at Western University, focusing on radiomics and machine learning applications in stereotactic radiosurgery. David also has a MSc in physics from Queen's University and a joint honours in Physics and Computer Science from the University of Waterloo. David's current research interests include artificial intelligence applications in radiation therapy, ranging from immediate clinical applications to long-term reimagining of our health data landscape. David is a member of the national CADRA initiative and COMP's CWC-IDEA group.
Darby Erler MRT(T), MHSc
Darby Erler MRT(T), MHSc is the Manager for Radiation Therapy at the Sunnybrook Odette Cancer Centre and Program Director for the University of Toronto Department of Radiation Oncology’s MR-Integrated Radiation therapy Training Program. She completed her degree in Radiation Sciences through the Joint Michener Institute/ University of Toronto Medical Radiation Science program in 2003 and a Master of Health Science in Medical Radiation Sciences from the University of Toronto in 2015. She holds a status appointment as Instructor in the Department of Radiation Oncology, University of Toronto and a Practice-Based Researcher through the Sunnybrook Research Institute. In a previous role as Clinical Specialist Radiation Therapist, she helped lead the clinical implementation of Sunnybrook’s MR-Linac program and continues to work on enhancing the integration of MRI into radiation therapy and maximizing the scope of practice of radiation therapists, particularly in the realm of adaptive radiation therapy.
